HELLARD ET / Lancet / Victoria / Vancouver / Parkville / Amsterdam / Melbourne / Edinburgh / /
Company
Bayer / Novartis / Johnson and Johnson / Merck / Challenges Limited / Bristol-Myers Squibb / /
Country
United States / Vietnam / Canada / Australia / Scotland / /
Currency
GBP / / /
Facility
The Alfred Hospital / Royal Melbourne Hospital / Burnet Institute / St Vincent’s Hospital / Monash University / / /
IndustryTerm
Treatment of hepatitis C / HCV therapy / health services / HIV prevention / care services / therapy for hepatitis C / Treatment of HCV / HCV therapies / social and injecting networks / HCV treatment / Prevention of HCV / treatment for hepatitis C / social network / /
MedicalCondition
HIV / highly effective hepatitis B / hepatitis C / hepatitis B / recently acquired hepatitis C / HCV infections / disease / Hopkins D. Disease / HCV / initial infection / HCV infection / virus infection / different epidemic settings / AIDS / hepatitis C. MJA / Infection / chronic infection / acute infection / chronic hepatitis C / /
MedicalTreatment
vaccination / counseling / antiviral therapy / /
Organization
National Health and Medical Research Council / Infectious Diseases Unit / Alfred Hospital / Centre for Research Excellence / Royal Melbourne Hospital / Centre for Population Health / Department of Epidemiology and Preventive Medicine / Burnet Institute / Victorian Infectious Disease Service / St Vincent’s Hospital / Monash University / Melbourne / Department of Gastroenterology / American Association for the Study of Liver Diseases / Lima V / Department of Health / /
Person
Maher L. Hepatitis / Dudley-Brown S. Adherence / Margaret Hellard / /
EDITORIAL Eradication of Hepatitis C Infection: The Importance of Targeting People Who Inject Drugs H